Survival outcomes from atezolizumab plus bevacizumab versus Lenvatinib in Child Pugh B unresectable hepatocellular carcinoma patients

被引：0

作者：

Margherita Rimini

Mara Persano

Toshifumi Tada

Goki Suda

Shigeo Shimose

Masatoshi Kudo

Jaekyung Cheon

Fabian Finkelmeier

Ho Yeong Lim

José Presa

Francesca Salani

Sara Lonardi

Fabio Piscaglia

Takashi Kumada

Naoya Sakamoto

Hideki Iwamoto

Tomoko Aoki

Hong Jae Chon

Vera Himmelsbach

Marta Schirripa

Margarida Montes

Caterina Vivaldi

Caterina Soldà

Atsushi Hiraoka

Takuya Sho

Takashi Niizeki

Naoshi Nishida

Christoph Steup

Masashi Hirooka

Kazuya Kariyama

Joji Tani

Masanori Atsukawa

Koichi Takaguchi

Ei Itobayashi

Shinya Fukunishi

Kunihiko Tsuji

Toru Ishikawa

Kazuto Tajiri

Hironori Ochi

Satoshi Yasuda

Hidenori Toyoda

Chikara Ogawa

Takashi Nishimura

Takeshi Hatanaka

Satoru Kakizaki

Noritomo Shimada

Kazuhito Kawata

Fujimasa Tada

Hideko Ohama

Kazuhiro Nouso

机构：

[1] Vita-Salute San Raffaele University,Department of Oncology

[2] IRCCS San Raffaele Scientific Institute Hospital,Department of Oncology

[3] IRCCS San Raffaele Hospital,Medical Oncology

[4] University and University Hospital of Cagliari,Department of Internal Medicine

[5] Japanese Red Cross Himeji Hospital,Department of Gastroenterology and Hepatology, Graduate School of Medicine

[6] Hokkaido University,Division of Gastroenterology, Department of Medicine

[7] Kurume University School of Medicine,Department of Gastroenterology and Hepatology, Faculty of Medicine

[8] Kindai University,Department of Medical Oncology

[9] CHA Bundang Medical Center,Department of Internal Medicine 1

[10] CHA University School of Medicine,Department of Medicine, School of Medicine

[11] University Hospital Frankfurt,Unit of Medical Oncology 2

[12] Goethe University,Department of Translational Research and New Technologies in Medicine and Surgery

[13] Samsung Medical Center,Oncology Unit 1

[14] Sungkyunkwan University,Division of Internal Medicine, Hepatobiliary and Immunoallergic Diseases

[15] Unidade de Hepatologia,Department of Nursing

[16] CHTMAD,Medical Oncology Unit, Department of Oncology and Hematology

[17] University Hospital of Pisa,Gastroenterology Center

[18] University of Pisa,Department of Gastroenterology and Metabology

[19] Veneto Institute of Oncology IOV-IRCCS,Department of Gastroenterology

[20] IRCCS Azienda Ospedaliero-Universitaria di Bologna,Department of Gastroenterology and Hepatology

[21] Gifu Kyoritsu University,Department of Hepatology

[22] Central Hospital of Belcolle,Department of Gastroenterology

[23] Strada Sammartinese Snc,Department of Gastroenterology

[24] Ehime Prefectural Central Hospital,Center of Gastroenterology

[25] Ehime University Graduate School of Medicine,Department of Gastroenterology

[26] Okayama City Hospital,Department of Gastroenterology

[27] Kagawa University,Hepato

[28] Division of Gastroenterology and Hepatology,Biliary Center

[29] Department of Internal Medicine,Department of Gastroenterology and Hepatology

[30] Nippon Medical School,Department of Gastroenterology

[31] Kagawa Prefectural Central Hospital,Department of Internal Medicine, Division of Gastroenterology and Hepatology

[32] Asahi General Hospital,Department of Gastroenterology

[33] Osaka Medical and Pharmaceutical University,Department of Clinical Research

[34] Teine Keijinkai Hospital,Division of Gastroenterology and Hepatology

[35] Saiseikai Niigata Hospital,Department of Hepatology

[36] Toyama University Hospital,Department of Surgery

[37] Japanese Red Cross Matsuyama Hospital,Department of Gastroenterology

[38] Ogaki Municipal Hospital,Department of Biomedical Sciences

[39] Japanese Red Cross Takamatsu Hospital,undefined

[40] Hyogo Medical University,undefined

[41] Gunma Saiseikai Maebashi Hospital,undefined

[42] National Hospital Organization Takasaki General Medical Center,undefined

[43] Otakanomori Hospital,undefined

[44] Hamamatsu University School of Medicine,undefined

[45] Kansai Medical University,undefined

[46] National Hospital Organization Takasaki General Medical Center,undefined

[47] Humanitas University,undefined

来源：

Journal of Cancer Research and Clinical Oncology | 2023年 / 149卷

关键词：

Advanced HCC; Atezolizumab; Bevacizumab; Real Word;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：7565 / 7577

页数：12

共 50 条

[1] Survival outcomes from atezolizumab plus bevacizumab versus Lenvatinib in Child Pugh B unresectable hepatocellular carcinoma patients
Rimini, Margherita
Persano, Mara
Tada, Toshifumi
Suda, Goki
Shimose, Shigeo
Kudo, Masatoshi
Cheon, Jaekyung
Finkelmeier, Fabian
Lim, Ho Yeong
Presa, Jose
Salani, Francesca
Lonardi, Sara
Piscaglia, Fabio
Kumada, Takashi
Sakamoto, Naoya
Iwamoto, Hideki
Aoki, Tomoko
Chon, Hong Jae
Himmelsbach, Vera
Schirripa, Marta
Montes, Margarida
Vivaldi, Caterina
Solda, Caterina
Hiraoka, Atsushi
Sho, Takuya
Niizeki, Takashi
Nishida, Naoshi
Steup, Christoph
Hirooka, Masashi
Kariyama, Kazuya
Tani, Joji
Atsukawa, Masanori
Takaguchi, Koichi
Itobayashi, Ei
Fukunishi, Shinya
Tsuji, Kunihiko
Ishikawa, Toru
Tajiri, Kazuto
Ochi, Hironori
Yasuda, Satoshi
Toyoda, Hidenori
Ogawa, Chikara
Nishimura, Takashi
Hatanaka, Takeshi
Kakizaki, Satoru
Shimada, Noritomo
Kawata, Kazuhito
Tada, Fujimasa
Ohama, Hideko
Nouso, Kazuhiro
[J]. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2023, 149 (10) : 7565 - 7577
[2] Survival outcomes from Atezolizumab plus Bevacizumab versus Lenvatinib versus Sorafenib in Child Pugh B unresectable hepatocellular carcinoma patients
Rimini, Margherita
Persano, Mara
Tada, Toshifumi
Suda, Goki
Shigeo, Shimose
Kudo, Masatoshi
Cheon, Jaekyung
Finkelmeier, Fabian
Lim, Ho Yeong
Presa, Jose
Lonardi, Sara
Piscaglia, Fabio
Chon, Hong Jae
Masi, Gianluca
Scartozzi, Mario
Cascinu, Stefano
Casadei-Gardini, Andrea
[J]. JOURNAL OF HEPATOLOGY, 2023, 78 : S592 - S592
[3] Outcomes of patients with Child-Pugh B and unresectable hepatocellular carcinoma undergoing first-line systemic treatment with sorafenib, lenvatinib, or atezolizumab plus bevacizumab
Kikugawa, Chihiro
Uchikawa, Shinsuke
Kawaoka, Tomokazu
Kinami, Takahiro
Yano, Shigeki
Amioka, Kei
Naruto, Kensuke
Ando, Yuwa
Yamaoka, Kenji
Tsuge, Masataka
Kosaka, Yumi
Ohya, Kazuki
Mori, Nami
Takaki, Shintaro
Tsuji, Keiji
Kouno, Hirotaka
Kohno, Hiroshi
Morio, Kei
Moriya, Takashi
Nonaka, Michihiro
Aisaka, Yasuyuki
Masaki, Keiichi
Honda, Yohji
Naeshiro, Noriaki
Hiramatsu, Akira
Aikata, Hiroshi
Oka, Shiro
[J]. ONCOLOGY, 2024, 102 (03): : 239 - 251
[4] Atezolizumab plus bevacizumab for patients with Child-Pugh-B in hepatocellular carcinoma
Itoh, Shinji
Ikeda, Masafumi
[J]. HEPATOBILIARY SURGERY AND NUTRITION, 2022,
[5] UNMET SYSTEMIC THERAPY NEED FOR CHILD-PUGH CLASS B PATIENTS WITH UNRESECTABLE HEPATOCELLULAR CARCINOMA - COMPARISON OF ATEZOLIZUMAB PLUS BEVACIZUMAB AND LENVATINIB
Ohama, Hideko
Hiraoka, Atsushi
Tada, Toshifumi
Hirooka, Masashi
Kariyama, Kazuya
Itobayashi, Ei
Kunihiko, Tsuji
Ishikawa, Toru
Toyoda, Hidenori
Hatanaka, Takeshi
Kakizaki, Satoru
Naganuma, Atsushi
Matono, Tomomitsu
Tada, Fujimasa
Nouso, Kazuhiro
Hiasa, Yoichi
Kumada, Takashi
[J]. HEPATOLOGY, 2023, 78 : S1907 - S1907
[6] Atezolizumab plus bevacizumab in Child-Pugh B advanced hepatocellular carcinoma patients
Kim, Hyeyeong
Cheon, Jaekyung
Ha, Yeongjung
Kim, Han Sang
Kim, Chang Gon
Kim, Ilhwan
Kim, Chan
Jung, Sang-Hoon
Chon, Hong Jae
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (04)
[7] Atezolizumab plus bevacizumab in patients with child-Pugh B advanced hepatocellular carcinoma
Cheon, Jaekyung
Kim, Hyeyeong
Kim, Han Sang
Kim, Chang Gon
Kim, Ilhwan
Kang, Beodeul
Kim, Chan
Jung, Sanghoon
Ha, Yeonjung
Chon, Hong Jae
[J]. THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2023, 15
[8] Efficacy of Atezolizumab Plus Bevacizumab Versus Lenvatinib in Patients with Unresectable Hepatocellular Carcinoma: a Meta-analysis
Mah I Kan Changez
Maimoona Khan
Muhammad Uzair
Muhammad Fawad Tahir
Maryam Mohsin
Amna Faiyaz Hussain
Vania Saqib
Muhammad Khizer Molani
Aisha Habib Ahmed
Saad Khalid
[J]. Journal of Gastrointestinal Cancer, 2024, 55 : 467 - 481
[9] Efficacy of Atezolizumab Plus Bevacizumab Versus Lenvatinib in Patients with Unresectable Hepatocellular Carcinoma: a Meta-analysis
Changez, Mah I. Kan
Khan, Maimoona
Uzair, Muhammad
Tahir, Muhammad Fawad
Mohsin, Maryam
Hussain, Amna Faiyaz
Saqib, Vania
Molani, Muhammad Khizer
Ahmed, Aisha Habib
Khalid, Saad
[J]. JOURNAL OF GASTROINTESTINAL CANCER, 2024, 55 (01) : 467 - 481
[10] SIMILAR EFFICACY AND SAFETY BETWEEN LENVATINIB VERSUS ATEZOLIZUMAB PLUS BEVACIZUMAB FOR UNRESECTABLE HEPATOCELLULAR CARCINOMA
Su, Chung-Wei
Teng, Wei
Lin, Po-Ting
Jeng, Wen-Juei
Chen, Kuei-An
Hsieh, Yi-Chung
Chen, Wei-Ting
Hou, Ming-Mo
Hsieh, Chia-Hsun
Lin, Chen-Chun
Lin, Chun-Yen
Lin, Hsi-Ming
[J]. HEPATOLOGY, 2022, 76 : S1415 - S1415

← 1 2 3 4 5 →